Table: Kringle Pharma - 9-MTH parent results

Kringle Pharma

09/08/2024 07:40

Aug 9 (Reuters)- 
             Kringle Pharma, Inc. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended        Year to   
                Jun 30, 2024        Jun 30, 2023       Sep 30, 2024  
                   LATEST             YEAR-AGO            LATEST     
                   RESULTS             RESULTS           FORECAST    
  Sales            61 mln              51 mln             79 mln     
                 (+19.3 pct)         (-54.0 pct)       (+14.8 pct)   
  Operating     loss 579 mln        loss 620 mln        loss 1.00    
  Recurring     loss 517 mln        loss 577 mln       loss 940 mln  
  Net           loss 518 mln        loss 578 mln       loss 942 mln  
  EPS          loss 82.76 yen      loss 107.45 yen   loss 147.23 yen 
  Ann Div                                NIL               NIL       
  -Q2 div            NIL                 NIL                         
  -Q4 div                                NIL               NIL       
  
  NOTE - Kringle Pharma, Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4884.T